Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index; 6 of the 23 sources its claims cite were checked for support.

Outcomes of an adapted prolonged exposure psychotherapy for people with early phase psychosis, substance misuse, and a history of adversity: the PE + trial

Open access

Abstract

Background: Several adversity-focused treatment trials have reported improvements to adversity sequelae (e.g., PTSD symptoms) and decreases in psychotic symptoms among individuals with psychotic disorders. Yet, no trials have examined the impact of adversity-focused treatment on substance use or examined the outcomes among an early phase psychosis population. These gaps in both the research literature and clinical practice have resulted in less knowledge about the outcomes of adversity-focused treatment at this stage of illness, including the impact on substance use. Methods: The outcomes of an adapted prolonged exposure protocol (PE+) among an early phase psychosis population were examined using a multiple-baseline design. Nineteen adults with a psychotic disorder, current substance misuse, and a history of adversity were recruited from an early psychosis program. Participants were randomized to treatment start time and participated in a 15-session course of PE + therapy. Ten assessments were completed focusing on primary outcomes (i.e., adversity sequelae, negative psychotic symptoms, substance misuse) and secondary outcomes (i.e., functioning, hopelessness, experiential avoidance). The Reliable Change Index (RCI) was used to establish whether there were clinically significant changes to primary or secondary outcomes. Results: Half or more of treatment completers experienced clinically significant changes to most domains of adversity sequelae, no participants experienced improvements in negative psychotic symptoms, and substance misuse increased for several participants. In terms of secondary outcomes, functioning and experiential avoidance were improved for a number of participants, while hopelessness decreased for only one participant. Participants reported high satisfaction with the PE + treatment, and exposure and coping skills were rated as the most helpful elements of treatment. Conclusions: Reductions in adversity sequelae were observed following PE + treatment, suggesting that adversity-focused treatment may be beneficial for an early psychosis population. Yet, few positive changes to psychotic symptoms or substance use were observed. Further integrating treatment strategies for psychosis and substance use into PE + may be required to effectively treat the links between psychosis, adversity sequelae, and substance use. Future studies should make efforts to integrate substance use strategies into adversity treatment trials for people with psychotic disorders. Trial registration: Clinicaltrials.gov, NCT04546178; registration posted 11/09/2020, https://clinicaltrials.gov/ct2/show/NCT04546178?term=NCT04546178&draw=2&rank=1. © The Author(s) 2024.

Overview

CoChat Summary

## TL;DR

This pilot PE+ trial tested an adapted 15-session prolonged exposure protocol for 19 adults in an early psychosis program who had psychotic disorders, current substance misuse, and adversity histories. It found clinically significant improvements in many adversity-related symptoms, but little change in negative psychotic symptoms and mixed or worsening substance-use outcomes.

## Key findings

  • Of the 19 participants, 15 started treatment and 12 completed it; 4 dropped out during baseline and 3 during treatment, and no serious adverse events were reported.
  • By follow-up, 83% of participants showed improvement or clinically significant change on the TSC-40 total score, and 58% achieved clinically significant change; 58.3% achieved clinically significant change on the abbreviated PCL-5.
  • For secondary outcomes, 33% experienced clinically significant improvement in experiential avoidance and 46.7% improved in functioning, but only 6.7% showed meaningful change in hopelessness.
  • Psychosis and substance use changed little overall: no participants improved in negative psychotic symptoms, 2 participants (16.7%) improved in positive psychotic symptoms, and substance misuse increased for several participants; the authors report 16.7% (2/12) had clinically significant improvement in substance use by follow-up, while 40% (6/15) had temporary substance-use improvements during the study that were not maintained.

## Methods

  • Multiple-baseline design with randomization to a 2-, 3-, or 4-week delay before treatment; 10 assessments were completed across baseline, treatment, and follow-up.
  • Recruited 19 adults from the Nova Scotia Early Psychosis Program; inclusion required age 19–35, schizophrenia-spectrum diagnosis within 5 years, current substance misuse, and a history of adversity affecting life.
  • Participants received 15 weekly 90-minute PE+ sessions, an adapted prolonged exposure protocol with psychoeducation, DBT-informed coping skills, imaginal exposure, in vivo exposure, and relapse prevention; analysis used a stringent intent-to-treat approach with Reliable Change Index and descriptive treatment-fidelity/feedback summaries.

## Limitations

  • The paper states that the results are limited by sample size and limited diversity of race and culture.
  • The small sample is also evident in the design: inferential statistics were not deemed appropriate, and the study relied on clinically significant change rather than statistical testing.
  • Evidence of generalizability limits is also evident from the setting and sample: participants were recruited from one early psychosis program in Halifax, and most participants were white.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12888-024-06050-1

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Participant recruitment information
Fig. 1 Participant recruitment informationCC BY · PubMed Central
Fig. 2 RCI scores for primary outcomes (TSC-40 total, alcohol, cannabis) and positive psychotic symptoms
Fig. 2 RCI scores for primary outcomes (TSC-40 total, alcohol, cannabis) and positive psychotic symptomsCC BY · PubMed Central
Fig. 3 RCIs for TSC-40 subscales (anxiety, depressive symptoms, dissociation, sleep) across PE+ treatment
Fig. 3 RCIs for TSC-40 subscales (anxiety, depressive symptoms, dissociation, sleep) across PE+ treatmentCC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 1 Not valid · 9 Not checked · 21 Own results and interpretations

13 more claims

Create a free account to see all 35 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 6
  • It may state two separate claims as one. 12
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 48 references

Research works printed but not linked: 3

  1. Guy W. Clinical global impression. Assessment manual for psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare; 1976.
  2. Linehan M. DBT Skills Training Manual: Second Edition. 2nd ed. New York, NY, US: Guilford Press; 2014.
  3. Sherrill A, Zwiebach L, Burton M, Fenlon E, Rauch SA, Rothbaum B. Emory University prolonged exposure (PE) consultant training program supplemental materials. Emory University; 2020. pp. 1–46.

Cited by

See all 1

Metadata

Authors
Patterson, V. C., Tibbo, P. G., Stewart, S. H., Town, J., Crocker, C. E., Ursuliak, Z., Lee, S., Morrison, J., Abidi, S., Dempster, K., Alexiadis, M., Henderson, N., & Pencer, A.
Affiliations
  • Dalhousie University (CA)
  • Nova Scotia Health Authority (CA)
Corresponding author
Patterson, Victoria C
Venue
BMC Psychiatry
Published
2024-10-14
Volume
24
Issue
1
Pages
684-684
ISSN
1471-244X (ISSN-L)
OpenAlex
W4403394103
Cited by
1
References
48
Citations by year
2025: 1
FWCI
0.50
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Research Nova Scotia (2022-2410)
  • Killam Trusts
  • QEII Foundation (1025210)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
prolonged exposure therapy, early psychosis, substance abuse, post-traumatic stress disorder, negative psychotic symptoms, experiential avoidance, hopelessness, treatment outcomes, treatment satisfaction
MeSH terms
Adult, Female, Humans, Implosive Therapy, Male, Psychotic Disorders, Treatment Outcome, Outcome Assessment, Health Care, Substance-Related Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes of an adapted prolonged exposure psychotherapy for people with early phase psychosis, substance misuse, and a history of adversity: the PE + trial. https://app.cochat.ai/papers/10.1186/s12888-024-06050-1
The paper
Patterson, V. C., Tibbo, P. G., Stewart, S. H., Town, J., Crocker, C. E., Ursuliak, Z., Lee, S., Morrison, J., Abidi, S., Dempster, K., Alexiadis, M., Henderson, N., & Pencer, A. (2024). Outcomes of an adapted prolonged exposure psychotherapy for people with early phase psychosis, substance misuse, and a history of adversity: the PE + trial. BMC Psychiatry. https://doi.org/10.1186/s12888-024-06050-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.